PRTA
Prothena Corporation PLC
Price:  
8.84 
USD
Volume:  
931,619.00
Ireland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTA Relative Valuation

-138.5%
Upside

As of 2026-10-10, the Relative Valuation of Prothena Corporation PLC (PRTA) is (3.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.84 USD, the upside of Prothena Corporation PLC based on Relative Valuation is -138.5%.

The range of the Relative Valuation is (1.88) - (12.07) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 2.2x - 14.4x 2.8x
Forward P/E multiples 2.1x - 14.4x 5.3x
Fair Price (1.88) - (12.07) (3.40)
Upside -121.3% - -236.5% -138.5%
8.84 USD
Stock Price
(3.40) USD
Fair Price

PRTA Relative Valuation - Historical P/E Data

Date P/E
2026-10-08 -10.25
2026-10-07 -10.09
2026-10-06 -9.54
2026-10-05 -9.84
2026-10-02 -9.95
2026-10-01 -10.16
2026-09-30 -9.97
2026-09-29 -10.45
2026-09-28 -10.38
2026-09-25 -9.87
2026-09-24 -9.90
2026-09-23 -10.33
2026-09-22 -10.70
2026-09-21 -10.13
2026-09-18 -10.21
2026-09-17 -10.07
2026-09-16 -9.81
2026-09-15 -9.91
2026-09-14 -10.54
2026-09-11 -10.63
2026-09-10 -10.73
2026-09-09 -11.07
2026-09-08 -11.35
2026-09-04 -11.69
2026-09-03 -11.42
2026-09-02 -11.53
2026-09-01 -11.44
2026-08-31 -11.13
2026-08-28 -11.10
2026-08-27 -10.82
2026-08-26 -11.01
2026-08-25 -11.21
2026-08-24 -11.17
2026-08-21 -11.25
2026-08-20 -10.75
2026-08-19 -11.05
2026-08-18 -10.36
2026-08-17 -10.57
2026-08-14 -10.54
2026-08-13 -10.81
2026-08-12 -11.02
2026-08-11 -10.97
2026-08-10 -10.85
2026-08-07 -10.42
2026-08-06 -10.21
2026-08-05 -10.10
2026-08-04 -10.10
2026-08-03 -9.91
2026-07-31 -9.66
2026-07-30 -10.01